You are here
- Home
- Therapy Areas
- Oncology/Infection
A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Hairy Cell Leukemia (HCL)
- Disease
- leukaemia
- Drug Name
- CAT-8015
- Generic Name
- CAT 8015
- Sponsor
- MedImmune
- Drug Status
- In Development
- Phase
- I
- Start Date
- May 10, 2007
- Study Name
- CAT-8015-1001
- Study Id
- CAT-8015-1001
- ClinicalTrials.gov ID
- NCT00586924
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
